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Protein isolates are a growing market share in the food industry both as food ingredients
and as supplements. All dietary habits can influence and alter the gut microbiome; however, little
is known about how protein isolates from different sources will change the composition and
function of the gut microbiota under high and low fiber conditions. The study aims to determine
the microbiome response to plant and animal protein isolates under high- and low-dietary fiber
(H/LDF) conditions. Six commercially available protein isolates (beef, egg white, milk, pea, and
two soy protein isolates) were subjected to in vitro enzymatic digestion and dialysis followed by
in vitro fermentation with four microbiomes differing in dietary history. Two fermentation media
containing 0.1% and 1% fermentable carbohydrate simulated LDF and HDF conditions,
respectively. Plant protein isolates, which were all from legumes, had similar amino acid
profiles, while the animal protein isolates had very different amino acid profiles depending on
source. Under the HDF condition, the microbiome was primarily saccharolytic and there were
minimal differences in fermentation properties among the different digested protein isolates. In
contrast, under the LDF condition, the microbiome was proteolytic, as evidenced by decreases in
peptide concentrations during fermentation and unique shifts in microbiome composition and
function during fermentation of the digested protein isolates. Under the LDF condition, digested
milk protein isolate increased the abundance of bacteria in the Clostridia class and the

Firmicutes phylum with concomitant increases in butyrate production. Flavonifractor and
Intestinimonas, genera with butyrate-producing pathways, were identified as differentially
abundant genera associated with digested milk protein isolate after 24 h of fermentation. Soy
proteins also resulted in high butyrate production, but induced increases in
Uncl_Lachnospiraceae, Lachnoclostridium, and Butyricicoccus genera, suggesting a different
pathway for butyrate production compared with digested milk protein isolate. Although digested
milk protein and soy protein isolates resulted in high butyrate production, they also led to the
highest concentrations of undesirable protein fermentation metabolites, ammonia and cadaverine,
during fermentation. Several amino acids were found to be significantly correlated to metabolite
production under the LDF condition, with glutamate and proline having a significantly positive
correlation with butyrate production. In conclusion, digested protein isolates have differential
effects on the gut microbiome, but only under conditions where dietary fiber is limited. Notably,
digested milk and soy protein isolates were highly butyrogenic and increased abundance of some
beneficial gut microbial taxa, but also led to high concentration of deleterious protein
fermentation metabolites.
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CHAPTER 1 REVIEW OF THE EFFECT OF A HIGH-PROTEIN, LOW-FIBER DIET
ON THE MICROBIOTA COMPOSITION AND METABOLITE PRODUCTION

1.1. ABSTRACT
Consumption of protein isolates has increased over the past years, and more healthconscious consumers are demanding plant protein isolates. In addition, many consumers are
overconsuming dietary protein while underconsuming dietary fiber, which may have a negative
impact on the human gut microbiome. When fiber and proteins escape digestion, they enter the
colon and are metabolized by the microbiota. Whether carbohydrate metabolism or protein
metabolism predominates depends on microbiome composition, substrate availability, and
energy needs. During saccharolytic fermentation bacteria produce metabolites such as shortchain fatty acids (SCFA) that can be beneficial to human health. Proteolytic fermentation can
also result in SCFA production but is also accompanied by branch-chain fatty acids (BCFA) and
other metabolites thought to be harmful to host metabolism, including ammonia, amines,
phenols, and indoles. The addition of fiber to a high-protein diet can reduce the production of
proteolytic fermentation metabolites.
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1.2. INTRODUCTION
Protein isolates, or protein powders, are food ingredients and nutritional supplements
where the protein is extracted through acid precipitation or ultrafiltration from high protein foods
(Alibhai et al., 2006; Fuhrmeister & Meuser, 2003; Reis & Zydney, 2010). Protein isolates are
comprised of at least 80% total protein and can be produced from both animal and plant protein
sources (Ismail et al., 2020; US Dairy Export Council, 2004). Demand for protein powders has
grown considerably in the last decade (Ismail et al., 2020). The global protein supplements
market size was valued at 20.47B USD in 2021 with a projected annual growth rate of 8.5% to
2030 (Grand View Research, 2020). Animal-based protein supplements, specifically whey and
casein protein, led the global market in 2021 and represented 65% of the market share. Soy and
wheat proteins were the most consumed plant protein isolates in 2021 (Grand View Research,
2020). While a majority of consumers tend to choose animal protein isolates, the popularity of
plant protein isolates is increasing (Ismail et al., 2020). The increase in plant protein isolates can
be attributed to consumers’ concern for health-related benefits, environmental concerns and
social concerns (Banovic et al., 2018; Cramer et al., 2017; de Boer et al., 2014).
Protein isolates have been associated with numerous health and performance-related
benefits (Badger et al., 2005; Sharp et al., 2015); however, other areas of health, such as the gut
microbiome, can be affected by adding protein isolates into a diet. With a high-protein diet, more
dietary proteins and peptides enter the colon for fermentation (Yao et al., 2016). A high-protein
diet combined with a low-fiber diet will further increase proteolytic fermentation as there is a
lack of dietary carbohydrates available for metabolism. There is little research surrounding the
fermentation and metabolite production of protein isolates, and, with the rapid increase of protein
isolates included in an American’s daily diet, it is important to understand the effect and
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influence of protein isolates on gut health. The objective of this review was to explore the
expanding market of protein isolates, the dietary trends surrounding a high-protein, low-fiber
diet, and how the microbiome responds to a high-protein, low-fiber diet through the production
of fermentation metabolites and changes in microbial composition.
1.3. PROTEIN AND HEALTH
Amino acids are small organic molecules containing an amino group, carboxyl group and
a specific, categorizing organic R group, or side chain. Nine amino acids (histidine, isoleucine,
leucine, lysine, methionine, phenylalanine, threonine, tryptophan and valine) are not synthesized
by humans; therefore, are essential to receive from the diet. The other eleven amino acids
(alanine, aspartate, asparagine, arginine, cysteine, glutamate, glutamine, glycine, proline, serine
and tyrosine) can be synthesized in the body and are considered non-essential amino acids. Most
animal sources of dietary protein provide a complete source of protein (i.e., containing all nine
essential amino acids) (Hoffman & Falvo, 2004). A few plant proteins are considered a complete
source of protein (e.g., soy, hemp and buckwheat), while other plant sources of dietary protein
lack one or more essential amino acid (Hoffman & Falvo, 2004; Michelfelder, 2009). In plant
sources, some legumes (e.g., chickpea, lentil, cowpea and green pea) are low in sulfur-containing
amino acids (Iqbal et al., 2006), while cereal grains are deficient in lysine (Shewry, 2007).
However, a well-balanced diet, diverse in dietary protein from plant sources should provide
sufficient intake of essential amino acids.
While protein intake is essential for human function, the protein source could have a
positive or negative influence on overall human health. Animal and plant protein sources have
shown a significant difference in their effect on overall human physiology (Kitada et al., 2019;
Sluijs et al., 2010). Protein isolates could provide different physiological effects than their
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corresponding whole protein. Whole protein sources, such as beef and eggs, contain saturated
fatty acids and cholesterol and are associated with cardiovascular disease (Li et al., 2013; Pighin
et al., 2016). However, protein isolates contain pure protein which could influence human health
differently than their corresponding whole protein sources. Whey protein has many physiological
effects, such as increased bone health, cardiovascular health, and physical performance (Solak &
Akin, 2012). Additionally, soy protein isolate has been shown to improve blood pressure (Teede
et al., 2001) and reduce body fat (Aoyama et al., 2000). However, research regarding other
prominent protein isolates is less known, as overall protein isolate research is aimed at body
composition and athletic performance and neglects to investigate other areas of health, including
gut health (Sharp et al., 2015; Valenzuela et al., 2019).
1.4. TRENDS IN PROTEIN AND FIBER INTAKE
A diet is considered high in protein if it exceeds the recommended dietary allowance
(RDA) of 0.8 grams per kilogram of body weight, or 62 and 72 grams per day for the average
American female and male, respectively (Trumbo et al., 2002; Walpole et al. 2012). In
comparison to the estimated average requirement (EAR) for dietary protein intake, over 97% of
adult Americans are getting enough protein (Fulgoni, 2008). Dietary trends show that most
protein comes from consumption of meats, poultry and eggs, while the average intake of plant
protein sources, specifically beans, peas and lentils, are underconsumed by Americans (United
States Department of Agriculture, 2020).
While Americans are overconsuming protein foods, they are neglecting foods high in
fiber. Roughly 90 percent of women and 97 percent of men do not meet the recommended
intakes for fiber, which aligns with the underconsumption of fiber-rich foods: whole grains, nuts,
seeds, fruits and vegetables (United States Department of Agriculture, 2020). Adequate
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carbohydrate intake is not a concern for Americans; however, the majority of Americans are
underconsuming fiber-rich carbohydrates that contain vitamins, trace minerals and other
components which positively impact overall health (Chen et al., 2016; Korczak & Slavin, 2020;
Lie et al., 2018; Slavin, 2000; Wolk et al., 1999; Yang et al., 2015). In addition to the adverse
health effects, the human gut microbiome can also be altered by a surplus of protein and
inadequate fiber consumption.
1.5. THE GUT MICROBIOME
The human gut microbiome is composed of bacteria, archaea, viruses, and eukaryotic
organisms (Tap et al., 2009; Zhernakova et al., 2016). In addition, the microbiome also includes
the metabolic functions of the microorganisms present; therefore, the gut microbiome can be
referred to as the hidden metabolic ‘organ’ (Guinane & Cotter, 2013). Individuals are estimated
to host 200 to more than 1000 microbial species with over 90% of the microbial organisms
belonging to the Bacteroidota and Firmicutes phyla (Mills et al., 2019; Qin et al., 2010;
Rinninella et al., 2019). The majority of the organisms present in the large intestine are obligate
anaerobes (Macfarlane & Macfarlane, 2012).
The human gut microbiome is composed of microbial organisms that play a significant
role in metabolic and immune functions and can be influenced by dietary habits (David et al.,
2014; Wu Gary et al., 2011), environment (Rothschild et al., 2018), lifestyle (Keohane et al.,
2020), genetics (Goodrich et al., 2014), and antibiotic use (Francino, 2016). Dysbiosis, or the
alteration in composition of the microbial communities in the gut microbiome, can be linked to
intestinal diseases such as inflammatory bowel disease (Ott et al., 2004) and irritable bowel
syndrome (Rinninella et al., 2019). Other disease states distant to the digestive tract have been
linked to the microbiome, such as allergies (Azad et al., 2015; Savage et al., 2018), obesity
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(Aoun et al., 2020; Koliada et al., 2017) and cardiovascular disease (Karlsson et al., 2012);
however, in many cases it is unknown whether dysbiosis plays a causal role or is the effect of the
disease state.
1.6. DIGESTION
Throughout the human gastrointestinal tract, food comes in contact with varying pH
conditions (Evans et al., 1988), digestive enzymes (Janiak, 2016; Whitcomb & Lowe, 2007) and
bile salts (Maldonado-Valderrama et al., 2011) to break down the food components into
molecules that can be absorbed. In vitro digestion (Brodkorb et al., 2019; Minekus et al., 2014;
Shani-Levi et al., 2017) and in vivo (Egger et al., 2017; Sanchón et al., 2018) models can be
beneficial in demonstrating the conditions of the human gastrointestinal tract. In vivo trials can
be challenging due to the complexity and overall cost; therefore, with the development of the
static in vitro simulation models, these models can accurately simulate the digestion of food.
Egger et al. (2017) confirmed the INFOGEST in vitro model is comparable to an in vivo pig
digestion of digested skim milk powder due to similarity in peptide patterns and the release of
free amino acids. Similarly, Sanchón et al. (2018) found the INFOGEST in vitro protocol
accurately resembled the in vivo digestion of casein and whey protein powders concerning
protein degradation and peptide release. Importantly, the in vitro model is adequate for both
carbohydrate (Fernandes et al., 2020; Ferreira-Lazarte et al., 2017) and protein (SantosHernández et al., 2020; Sousa et al., 2020) digestion.
Through in vitro digestion models, the protein digestibility of high protein foods can be
measured to estimate the percentage of amino acids available to the organism after digestion. It is
well accepted that animal proteins, specifically egg, milk, and meats, have significantly high
digestibility (>95%), while plant proteins with cell walls intact have digestibility ranging from
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50% to 80% (Santos-Hernández et al., 2020; Tomé, 2013). However, with food processing
techniques, including the production of protein isolates, the digestibility of plant proteins can be
improved (Drulyte & Orlien, 2019; Sá et al., 2020). In legume proteins, Aryee & Boye (2016)
showed the digestibility of raw lentil was 77% and increased to 85% with lentil protein isolate.
In addition, the in vitro digestibility a chickpea protein (76.2 %) increased after alkaline
extraction (96.1%) (Sánchez-Vioque et al., 1999). With food processing techniques, protein
isolates can achieve significantly higher protein digestibility and become closer to animal protein
digestibility.
1.7. CARBOHYDRATE FERMENTATION
Similar to digestion methods, there are both in vitro and in vivo techniques that model
human colonic fermentation. While in vivo fermentations offer the best representation of colonic
fermentation, they also include various limitations such as their expensive nature, ethical
concerns, and a lack of easy access to the colon (Venema & van den Abbeele, 2013). Therefore,
in vitro fermentation techniques are an effective method to closely mimic the microbial activity
in the colon and form insights before conducting in vivo studies. In vitro fermentation models
vary from batch fermentations, where microbes grow statically in an anaerobic environment, to
dynamic fermentation models (Gibson et al., 1988; Minekus et al., 1999), where the fermentation
vessel has constant turnover of fresh medium which removes dead cells and fermentation
metabolites.
Following digestion, roughly 20-60 g of dietary carbohydrates will escape enzymatic
digestion and reach the colon for fermentation (Flint et al., 2012). Dietary fibers are primarily
composed of plant cell wall polysaccharides (e.g., cellulose, hemicellulose, xylan, pectin, inulin)
(Lovegrove et al., 2017), but there are animal-derived polysaccharides (e.g., chitin) which are
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generally low in the American diet (Lopez-Santamarina et al., 2020). Fibers are resistant to
digestive enzymes in the small intestine and, therefore, provide a significant source of energy for
the microbial community (Cummings & Macfarlane, 1991; Flint et al., 2012; Mudgil & Barak,
2013). Under a fiber-rich diet, many of the microbes present in the human gut microbiome are
saccharolytic organisms which derive energy from complex carbohydrate breakdown. Through
an in vitro fermentation with a mixture of fiber-rich media, Aguirre et al. (2016) found a phylumdependent response which enriched for species belonging to the phyla Firmicutes,
Actinobacteria, Fusobacteria and Verrucomicrobia compared to a high-protein media which
enriched Bacteroidota. In human studies, De Filippo et al. (2010) compared the microbiota of
children from Europe and a rural African village of Burkina Faso, where the average diet is high
in fiber content. Interestingly, the African children had Prevotella and Xylanibacter, which can
metabolize cellulose and xylan, respectively, while these genera were lacking in the European
children. In contrast, the European children had higher abundance of potentially pathogenic
microbes, Shigella and Escherichia, than the African children. In addition, Costabile et al. (2008)
conducted a human feeding study with 100% whole grain wheat breakfast cereal (48 g/d), and
subjects had increased abundance of Bifidobacterium and Lactobacillus, two of the most targeted
genera by prebiotics, compared to when subjects consumed the placebo breakfast cereal.
Research well explains the differences in microbiota composition caused by fibers in media
cultures and diets, in vitro and in vivo, respectively; however, less is known about the effect of
proteins and peptides entering the colon for fermentation.
1.8. PROTEIN FERMENTATION
Research estimates that around 6-18 g of dietary protein reach the large intestine daily for
fermentation (Yao et al., 2016). The quantity of protein entering the colon is dependent on the
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total protein intake, in addition to the amino acid composition and protein digestibility
(Gaudichon et al., 2002; Vidal-Lletjós et al., 2017). Several studies indicate protein intake alters
the composition of the gut microbiota and the enrichment of specific amino acid fermenting
species or detraction of saccharolytic organisms (Figure 1.1). Through a series of enumeration,
isolation and identification of amino acid fermenting organisms, Smith & Macfarlane (1996b)
identified a range of species belonging to Bacteroides, Clostridium, Bifidobacterium,
Peptostreptococcus, Lactobacillus and Escherichia that were able to ferment amino acids. In
addition, Mead (1971) identified fifteen species of Clostridia that preferred utilization of casein
over glucose as an energy source. In a human study, David et al. (2014) showed an increase in
Alistipes, Bilophila, and Bacteroides and decreased abundance of saccharolytic organisms
(Roseburia, Eubacterium rectale and Ruminococcus bromii) when individuals consumed an
animal-based diet high in protein, fat and cholesterol compared to individuals on a plant-based
diet high in fiber. Similarly, Russell et al. (2011) placed healthy subjects on diets differing in
fiber and protein content. Compared to a maintenance diet (21.9 g/d of fiber and 85 g/d of
protein), a high-protein and low-fiber diet (8.8 g/d of fiber 137.7 g/d of protein) showed a
decrease in Roseburia and E. rectale.
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Dietary Carbohydrates
Bifidobacterium

Proteins
Clostridium

Alistipes
Dorea
Blautia

Eubacterium

Bacteroides

Ruminiclostridium Erysipelatoclostridium
Coprococcus
Roseburia

Parabacteroides
Lachnoclostridium

Prevotella

Veillonella

Ruminococcus

Escherichia

Figure 1.1. The major genera in the human gut microbiome that ferment dietary carbohydrates,
proteins or a combination (Oliphant & Allen-Vercoe, 2019).
1.9. FERMENTATION METABOLITES
During saccharolytic and proteolytic fermentation, the human gut microbiome produces
fermentation byproducts, or metabolites (Figure 1.2). During saccharolytic fermentation, bacteria
produce metabolites such as short-chain fatty acids (SCFA) that can be beneficial to human
health. Proteolytic fermentation can also result in SCFA production, but is also accompanied by
branch-chain fatty acids (BCFA) and other metabolites thought to be harmful to host
metabolism, including ammonia, amines, phenols, and indoles (Figure 1.3).
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Figure 1.2. The metabolites produced from carbohydrate and protein fermentation. Created with
BioRender.com.
SCFAs include acetate, propionate and butyrate and can reach concentrations of 50-200
mM in the human large intestine (Louis & Flint, 2017). Although SCFAs are the major
metabolite from saccharolytic fermentation, they are also produced from amino acid
fermentation. SCFAs are the most well studied fermentation metabolites and they have multiple
health benefits: anti-inflammatory effects (Vinolo et al., 2011), improved gut barrier function
(Pérez-Reytor et al., 2021) and mucus production (Shimotoyodome et al., 2000). In addition,
research indicates the importance of butyrate for colonic health by serving as colonocytes main
energy source (Parada Venegas et al., 2019). On the other hand, BCFAs, such as isovalerate,
isobutryate and 2-methylbutryate, are produced mainly from proteolytic fermentation of
branched chain amino acids (valine, leucine, and isoleucine). BCFAs are produced at
significantly lower concentrations than SCFAs and their impact on host health are less known
than SCFAs (Rios-Covian et al., 2020). However, research regards BCFAs as negative
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metabolites because they are associated with proteolytic fermentation and the production of other
toxic metabolites. David et al. (2014) examined the impact of extreme dietary interventions
(animal-based and plant-based) on the human gut microbiome, and the plant-based diet resulted
in significantly higher SCFAs while the animal-based diet resulted in significantly higher
BCFAs. Similarly, reduced fiber (27.9 g/d reduced to 6.1 g/d) of subjects showed a fifty percent
decrease in SCFA production, specifically butyrate production, and a decrease in abundance of
Roseburia, E. rectale and Bifidobacteria (Duncan et al., 2007). Aguirre et al. (2016) found
through in vitro fermentations that BCFAs increase with media abundant in protein, while a
media rich in fiber favored SCFA production. Rios-Covian et al. (2020) sampled 232 subjects
with varying age, BMI and dietary habits and found a negative correlation between the
consumption of dietary insoluble fiber and fecal levels of BCFAs. Research indicates the
importance of fiber intake to increase beneficial SCFAs, and reduce the proteolytic fermentation
metabolite, BCFAs. However, there is a lack of research understanding proteolytic fermentation
metabolites under different fiber conditions with protein isolates as the protein source.
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Figure 1.3. The metabolites produced from general and specific amino acid metabolism. Created
with BioRender.com
Ammonia, formed by the deamination of amino acids, is a toxic by-product of proteolytic
fermentation. High levels and sustained exposure to ammonia can harm colonocytes by
decreasing proliferation and causing DNA damage (Diether & Willing, 2019; Rowland et al.,
1998). Geypens et al. (1997) supplemented heathy subjects normal diet with a protein rich food
composed of whey, casein and lactalbumin for a total 58.2 g of supplemented protein per day for
one week. Compared to the subjects’ normal diets, the dietary supplementation of proteins
significantly increased the fecal concentration of ammonia. Similarly, Cummings et al. (1979)
compared four subjects ammonia production after three controlled diets: low-protein diet (62.7
g/d of dietary protein and 23.4 g/d of fiber), high-protein diet (136.0 g/d of protein and 21.8 g/d
of fiber) and high-protein with wheat fiber diet (164.0 g/d of protein and 53.2 g/d of fiber). The
high-protein diet increased ammonia production by 50% compared to the low-protein diet.
Surprisingly, they found that the supplementation of wheat fiber on the high-protein diet did not
reduce ammonia production. As previous research suggested the addition of fiber-rich foods
could reduce ammonia production due to saccharolytic fermentation being favored over
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proteolytic fermentation, the authors hypothesized that addition of wheat fiber led to increased
protein intake which could have counteracted the ammonia-lowering effect of the fiber or that
the wheat fiber was poorly fermentable and further increased nitrogen intake (Cummings et al.,
1979).
To understand the impact of fiber intake on ammonia reduction, researchers have used in
vitro experiments. Vince et al. (1990) used an in vitro fermentation system to explore the
production of ammonia from fibers by gut microbes. Fecal samples were incubated with added
lactulose, pectin, arabinogalactan and cellulose, both before and after subjects were fed the
dietary fibers. Compared to a control fermentation, pectin and arabinogalactan decreased
ammonia production when the subjects were fed these substrates, while lactulose significantly
decreased ammonia production regardless if the subjects were fed prior to in vitro fermentation.
Similarly, Smith & Macfarlane (1998) conducted an in vitro fermentation with culture media
containing either amino acids or peptides. The addition of starch (10 g/L) significantly reduced
the production of ammonia with the peptide (38%) or amino acid (44%) containing media,
respectively.
In addition to dietary habits, the gut microbiome composition can influence ammonia
production. Vince & Burridge (1980) determined which intestinal bacteria are most active in
forming ammonia from peptides and amino acids. Gram-negative anaerobes (Bacteroides spp.)
produced the highest quantities of ammonia, while gram-positive bacteria (Bifidobacteria and
Lactobacilli) produced modest to very little ammonia. Bacteroides spp., especially isolates of B.
fragilis and B. vulgatus, showed a wide range of production, but the majority of strains produced
more than 30 mmol ammonia/liter. In addition to Bacteroides spp., potentially pathogenic
bacteria (Clostridium perfringens, Escherichia coli) showed considerable production of
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ammonia. Similarly, potentially pathogenic Fusobacterium species produce butyrate through
multiple amino acid metabolism pathways, which releases ammonia as a by-product (Anand et
al., 2016). With the toxic effects of ammonia on human health, the most significant way to
reduce ammonia concentration is through dietary habits.
Similar to ammonia, unsubstituted phenolic and indolic compounds have multiple
negative health effects on colon cancer and kidney function (Dou et al., 2004; Smith &
Macfarlane, 1996a; Zhao et al., 2019). Phenols and indoles are produced mainly from
metabolism of the three aromatic amino acids (phenylalanine, tyrosine, and tryptophan) and,
therefore, are reflective of a proteolytic fermentation rather than saccharolytic fermentation. Both
unsubstituted and substituted phenolic and indolic compounds are produced, with a majority of
the negative health effects associated with unsubstituted compounds (Yao et al., 2016; Windey et
al. 2012). Degradation of tyrosine includes hydroxyphenylpyruvate, 4-hydroxyphenylacetate,
phenol and p-cresol, while phenylalanine produces similar metabolites, phenylpyruvate and
phenylacetate (Windey et al., 2012). Tryptophan degradation produces indole, skatole and indole
acetate (Windey et al., 2012). Toden et al. (2007) and Winter et al. (2011) found a reduction in
phenol and p-cresol concentrations in rats fed high-amylose maize starch in combination with
meat compared to rats fed meat without starch. Muir et al. (2004) established similar trends with
a human feeding study. When compared to a control diet with 2-5 g/d of resistant starch from
low-amylose maize and no wheat bran, a diet supplemented with 10-15 g fiber/d from wheat
bran and 20-30 g/d of resistant starch from high-amylose starch provided at 34 percent reduction
in total phenols, as well as a significant reduction in ammonia production. Similar to other
proteolytic metabolites, this indicates that fiber intervention can reduce the production of
negative fermentation metabolites, even phenolic and indolic compounds.
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While diet plays a critical role in mitigating proteolytic fermentation metabolites, the role
of microbial composition cannot be disregarded. Saito et al. (2018) used a culture based-assay
with tyrosine and predicted metabolic intermediates (4-hydroxyphenylpyruvate, DL-4hydroxyphenyllactate, 3-(p-hydroxyphenyl)propionate, 4-hydroxyphenylacetate and 4hydroxybenzoate) in supplemented media to screen for intestinal bacteria that can further
metabolize tyrosine or the metabolic intermediates to phenol, p-cresol or both. They found 16
phenol producing strains that produced more than 100 𝜇M of phenols which belonged to the
Coriobacteriaceae, Enterobacteriaceae, Fusobacteriaceae, and Clostridium clusters I and XIVa,
and four p-cresol-producing bacteria belonging to Coriobacteriaceae and Clostridium clusters XI
and XIVa. Additionally, Bifidobacterium spp., Lactobacillus spp., Peptostreptococcus spp. and
Clostridium spp. are associated with the metabolism of tryptophan to indole and indole
derivatives, in addition to the most widely studied indole-producing bacteria, E. coli (Li et al.,
2021). Lastly, Wikoff et al. (2009) and Sridharan et al. (2014) compared the production of
phenol and indole in conventional and germ-free mice, and found phenol was only detected in
conventional mice. These findings show the production of phenols and indoles are completely
dependent on the presence of the gut microbiome, emphasizing the importance of the microbial
community in the production of metabolites.
The dietary protein source and fiber intake modulates the human gut microbiome altering
the concentration of saccharolytic and proteolytic fermentation metabolites. In vitro and in vivo
studies have shown that under high-protein, low-fiber conditions, the microbiome produces
harmful proteolytic fermentation metabolites. In contrast, the addition of fiber can reduce the
production of proteolytic metabolites. However, much of the research involves whole protein
sources and neglects to understand if protein isolates have different effects on the microbiome. In
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conclusion, there is a lack of understanding surrounding protein isolates and their impact on the
microbiome and the associated production of harmful proteolytic fermentation metabolites that
can greatly influence host health.
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CHAPTER 2 IN VITRO FERMENTATION OF ANIMAL AND PLANT PROTEIN
ISOLATES BY THE HUMAN GUT MICROBIOME UNDER HIGH AND LOW FIBER
CONDITIONS
2.1 ABSTRACT
Protein isolates are a growing market share in the food industry both as food ingredients
and as supplements. All dietary habits can influence and alter the gut microbiome; however, little
is known about how protein isolates from different sources will change the composition and
function of the gut microbiota under high and low fiber conditions. The study aims to determine
the microbiome response to plant and animal protein isolates under high- and low-dietary fiber
(H/LDF) conditions. Six commercially available protein isolates (beef, egg white, milk, pea, and
two soy protein isolates) were subjected to in vitro enzymatic digestion and dialysis followed by
in vitro fermentation with four microbiomes differing in dietary history. Two fermentation media
containing 0.1% and 1% fermentable carbohydrate simulated LDF and HDF conditions,
respectively. Plant protein isolates, which were all from legumes, had similar amino acid
profiles, while the animal protein isolates had very different amino acid profiles depending on
source. Under the HDF condition, the microbiome was primarily saccharolytic and there were
minimal differences in fermentation properties among the different digested protein isolates. In
contrast, under the LDF condition, the microbiome was proteolytic, as evidenced by decreases in
peptide concentrations during fermentation and unique shifts in microbiome composition and
function during fermentation of the digested protein isolates. Under the LDF condition, digested
milk protein isolate increased the abundance of bacteria in the Clostridia class and the
Firmicutes phylum with concomitant increases in butyrate production. Flavonifractor and
Intestinimonas, genera with butyrate-producing pathways, were identified as differentially
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abundant genera associated with digested milk protein isolate after 24 h of fermentation. Soy
proteins also resulted in high butyrate production, but induced increases in
Uncl_Lachnospiraceae, Lachnoclostridium, and Butyricicoccus genera, suggesting a different
pathway for butyrate production compared with digested milk protein isolate. Although digested
milk and soy protein isolates resulted in high butyrate production, they also led to the highest
concentrations of undesirable protein fermentation metabolites, ammonia and cadaverine, during
fermentation. Several amino acids were found to be significantly correlated to metabolite
production under the LDF condition, with glutamate and proline having a significantly positive
correlation with butyrate production. In conclusion, digested protein isolates have differential
effects on the gut microbiome, but only under conditions where fiber is limited. Notably,
digested milk and soy protein isolates were highly butyrogenic and increased abundance of some
beneficial gut microbial taxa, but also led to high concentration of deleterious protein
fermentation metabolites.
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2.2. INTRODUCTION
Although the typical American diet is replete with protein, with over 97% of Americans
exceeding recommendations, this nutrient is widely sought out among consumers (Fulgoni,
2008; Ismail et al., 2020; U.S. Department of Agriculture and U.S. Department of Health and
Human Services, 2020). This has fueled the development of a robust protein isolate market that
continues to grow in market share and to expand to include protein isolates from new sources
(Grand View Research, 2020; Ismail et al., 2020).
In contrast, the average American diet lacks fiber, with more than 90% of women and
97% not meeting the recommended intakes for fiber (U.S. Department of Agriculture and U.S.
Department of Health and Human Services, 2020). Public health recommendations to increase
fiber intake have not been effective despite the associated health benefits (Howarth et al., 2001;
Keenan et al., 2002; Liu et al., 1999). Thus, the current dietary habits of Americans reflect a
high-protein, low-fiber diet.
These dietary habits can influence the gut microbiota based on undigested food
components escaping digestion in the small intestine and entering the colon for fermentation.
Depending on intake, 20-60 g of fiber will enter the colon daily (Flint et al., 2012). The
microbiome preferentially ferments fiber for energy, while proteins and peptides are primarily
used for anabolic biosynthesis rather than catabolism (Oliphant & Allen-Vercoe, 2019).
However, when there is a lack of dietary carbohydrates available, the microbiome can
metabolize proteins for energy even though saccharolytic fermentation is energetically favored
over protein fermentation (Yao et al., 2016). Anywhere from 6-18 g of dietary protein reach the
large intestine daily for fermentation, and the concentration is dependent on total protein intake,
amino acid composition and protein digestibility (Gaudichon et al., 2002; Vidal-Lletjós et al.,
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2017; Yao et al., 2016). An overconsumption of dietary protein, despite digestibility, is
hypothesized to saturate the digestive system and increase protein entering the colon (Geypens et
al., 1997).
During fermentation of either fibers or proteins for energy, the gut microbiota produces
metabolites that can influence host health. Saccharolytic metabolites, including short-chain fatty
acids (SCFA), are produced by gut microbes during carbohydrate metabolism and have
numerous beneficial effects on host health (Alexander et al., 2019; Canfora et al., 2015; Vinolo
et al., 2011). Research indicates the importance of butyrate for colonic health by serving as the
main energy source for colonocytes (Parada Venegas et al., 2019), maintenance of colonic
mucosal health (Canani et al., 2011), and acting as an anti-inflammatory agent (Inan et al., 2000).
In addition to supporting colonic health, butyrate has been shown to protect brain health by
increasing expression of genes related to neural regeneration and plasticity (Bourassa et al.,
2016) and to prevent and treat diet-induced obesity and insulin resistance in mouse models (Gao
et al., 2009). Fermentation of peptides and amino acids also results in SCFA, but also leads to
production of branched-chain fatty acids (BCFA) and a number of metabolites that can
negatively influence host health such as ammonia, amines, phenols and indoles (Macfarlane &
Macfarlane, 2012; Yao et al., 2016). These proteolytic compounds have been linked to damage
to the colonic mucus layer, increase in colonic epithelial permeability, and overall DNA damage
(Diether & Willing, 2019; Rios-Covian et al., 2020).
Habitual diet shapes an individual’s microbial community, and therefore, influences
metabolite production. De Filippo et al. (2010) found that children in rural Africa, who ate more
fiber-rich foods compared to European children, had significantly more Prevotella and
Xylanibacter which accounted for significantly higher fecal SCFA. On the other hand, the
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European children with a Western diet high in protein, sugar, and fat and low in fiber, had a
higher abundance of potentially pathogenic microbes, Shigella and Escherichia. Martínez et al.
(2015) and Yatsunenko et al. (2012) reported similar findings when comparing the microbiota of
Papa New Guineans, individuals from Venezuela, and individuals from Malawi to Americans,
respectively.
Proteolytic fermentation results in production of general metabolites resulting from
deamidation of amino acids (e.g. ammonia and amines); however, there are a number of
metabolites that arise from specific amino acids, including phenols (tyrosine), indoles
(tryptophan), and cadaverine (lysine) (Diether & Willing, 2019; Oliphant & Allen-Vercoe, 2019;
Windey et al., 2012). Thus, when proteins and peptides enter the colon for fermentation, the
amino acid composition is important in determining the proteolytic metabolites produced.
Several studies indicate an increase in protein consumption results in a significant
increase of protein specific fermentation metabolites (Cummings et al., 1979; Geypens et al.,
1997; Pieper et al., 2014; Russell et al., 2011). However, proteolytic fermentation can be reduced
with adequate fiber, even without altering protein intake (Muir et al., 2004; Yao et al., 2016). In
a randomized crossover study, Birkett et al. (1996) found that supplementation of resistant starch
(39 ± 3 g/d) compared to a low resistant starch diet (5 ± 0.4 g/d) significantly reduced fecal
concentrations of phenol and ammonia when all other macronutrients were kept constant. These
results suggest the ability of resistant starch to attenuate production of harmful fermentation
byproducts and the beneficial effects of fibers on protein fermentation.
There is evidence that protein and fiber intake, microbiome composition and the
composition of the protein source influence the microbial response. However, there is a lack of
research comparing how different protein isolates will influence the microbial response
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depending on carbohydrate availability. Thus, the objective of this study was to determine the
changes in gut microbiota composition and function during fermentation of protein isolates from
animal and plant sources under high- and low dietary fiber (H/LDF) conditions. Based on the
microbial communities present from habitual diets, we hypothesized that microbiomes with high
animal protein diets will preferentially ferment animal protein isolates, while the microbiomes
accustomed to a high plant protein diet, will preferentially ferment plant protein isolates.
Additionally, because of the importance of amino acid composition for metabolite production, it
is hypothesized plant and animal protein isolates will produce different proteolytic metabolites.
And lastly, given that bacteria prefer carbohydrate fermentation, it is hypothesized that high fiber
conditions will diminish the production of harmful proteolytic metabolites.
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2.3. MATERIALS AND METHODS
2.3.1. Materials
Six commercially-available protein isolates were sourced: beef (Prinova, Hanover Park,
IL, USA), bovine milk (Idaho Milk Products, Jerome, ID, USA), egg white (Henningsen Foods,
Omaha, NE, USA), pea (Naked Nutrition, Rochester, NY, USA), two soy protein isolates (Bob’s
Red Mill, Milwaukie, OR, USA and BulkSupplements.com, Henderson, NV, USA). Two
commercially-available soy protein isolates were included because other plant protein products
obtained contained protein concentrations that were much lower than the animal protein isolates.
For example, we sourced faba bean (Artesa Ingredients, Henrico, VA, USA), chickpea (Artesa
Ingredients, Henrico, VA, USA) and lentil (Artesa Ingredients, Henrico, VA, USA), but the
protein concentrations of these products were 58.2 ± 0.2%, 56.9 ± 0.2% and 53.1 ± 0.1%,
respectively, compared to the animal protein isolates which had protein concentrations > 80%
(measured as described in section 2.3.2).
2.3.2. Nitrogen Measurement
Total nitrogen concentration was measured with a nitrogen analyzer (FP 528, Leco, St
Joseph, MI, USA) and converted to protein concentration (%) with a universal conversion factor
of 6.25 (Jones, 1941). The nitrogen measurement was determined both before and after in vitro
enzymatic digestion and dialysis.
2.3.3. Amino Acid Profile
Amino acid distribution of the nondigested and enzymatically-digested protein isolates
was performed by the Proteomics & Metabolomics Facility at the University of NebraskaLincoln. Samples were hydrolyzed for 24 h using 0.5% phenol/6N HCl and derivatized as
described by Dhillon et al. (2014). Briefly, the hydrolyzed samples were dried and resuspended
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with 1 mL of 20 mM HCl. The reconstituted amino acids and hydrolysate standard amino acid
mixtures were derivatized with AccQ-Tag derivatization kit (186003836, Waters, Milford, MA,
USA). Next, amino acids were separately detected and quantified using UPLC (1290 Agilent
Infinity II) with a C18 column (ACCQ-TAG Ultra C18 1.7 μM, 2.1x100 mm). An external
standard curve was run with known concentrations of Ala, Arg, Asp, Cya, Glu, Gly, His, Ile,
Leu, Lys, MetSO2, Phe, Pro, Ser, Thr, Tyr, and Val. The concentrations were reported as percent
weight. During the process, tryptophan was destroyed and is therefore not reported.
2.3.4. SDS-PAGE
Sodium dodecyl sulfate–polyacrylamide gel electrophoresis (SDS-PAGE) was completed
with nondigested and enzymatically-digested protein isolates using a 4-20% gradient gel
(4561096, Bio-Rad, Hercules, CA, USA). Protein isolate stock solutions of 1 mg/mL were
prepared in double distilled water. The stock solution was further diluted to 30 µg with 2X
Laemmli loading buffer (1610737, Bio-Rad, Hercules, CA, USA). The solutions were loaded in
the gradient gel for electrophoresis and stained with Coomassie R250. After destaining, the gel
was scanned with an infrared imaging system, Odyssey CLX Imaging System (Li-Cor
Biosciences, Lincoln, NE, USA) and molecular weights were determined using Precision Plus
Protein Standards (1610374, Bio-Rad, Hercules, CA, USA).
2.3.5. Molecular Weight Distribution
The molecular weight profile of nondigested and enzymatically-digested protein isolates
was measured using size exclusion chromatography. Protein isolate stock solutions of 1 mg/mL
were prepared in phosphate buffer (50 mM sodium phosphate, 150 mM sodium chloride, pH 7.2)
and further diluted to 0.5 mg of protein/mL with buffer. Five hundred microliters of solution was
injected into a protein purification liquid chromatograph (ÄKTA pure, Cytiva, Marlborough,
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MA, USA). For nondigested samples, a Superdex peptide 200 10/300GL column (10 mm ×
300−310 mm, GE Healthcare Sweden) was used with a detection wavelength of 280 nm for
measuring absorbance of proteins. For digested samples, a Superdex peptide 30 10/300GL
column (10 mm × 300−310 mm, GE Healthcare Sweden) with a 214 nm wavelength was used
for measuring absorbance of peptides. The column was equilibrated with phosphate buffer at 0.8
mL/min for two column volumes and samples were eluted at 0.5 mL/min for two column
volumes. Molecular weight distribution of samples was determined by a standard curve with
compounds of varying molecular weights for raw materials (13700 – 670000 Da) and digested
samples (132-6511 Da). For both standard curves, the x-axis values (molecular weight) were logtransformed and the y-axis values (elution volume) were not transformed.
2.3.6. In vitro digestion
In vitro digestion was performed as described by Brodkorb et al. (2019) with slight
modifications. Protein isolates (8.5 g of protein) were dispersed in 85 mL of distilled water. To
the protein slurry, 6.8 mL of simulated salivary fluid, 13.6 mL of simulated gastric fluid and 50
µL of 0.3 M calcium chloride were added. Then, the pH was adjusted to 3 with 1 M HCl,
followed by the addition of 0.85 mL of pepsin (P7000, Sigma, St Louis, MO, USA) solution
(2000 U pepsin/mL) before incubation with shaking at 200 rpm at 37 °C for 2 h. Next, 18.7 mL
of simulated intestinal fluid and 68 µL of calcium chloride was added. The pH was adjusted to
pH of 7 with 1 M NaOH before the addition of 8.5 mL of pancreatin (P7545, Sigma, St Louis,
MO, USA) solution (100 U trypsin/mL final volume) prepared in simulated intestinal fluid. This
mixture was incubated with shaking at 200 rpm at 37 °C for 2 h. After digestion, the mixture was
transferred to dialysis tubing (1000 Da MWCO, 132105, Fischer Scientific, Hampton, NH, USA)
and dialyzed against distilled water at 4 °C for 3 d with a water change at least every 12 h.
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Finally, the dialysis retentate was freeze-dried (FreeZone Tray Dryer, Labconco, Kansas City,
MO, USA) and stored at -80 °C until analysis.
2.3.7. Fecal sample processing for in vitro fermentation
Thirty potential stool donors with no history of gastrointestinal diseases, no prebiotic or
probiotic use, no normal yogurt consumption, and no antibiotic use within the last six months
completed the Diet History Questionnaire III (DHQ III) from the National Institute of Health to
determine food frequency (NIH-NCI Epidemiology and Genomics Research Program, 2018).
Based on the questionnaire, four stool samples were selected according to the individual’s animal
or plant protein consumption. Ten grams of fresh fecal sample was stomach mixed (Bag Mixer
400 CC, Interscience, Saint Nom la Breteche, France) with a phosphate-buffered saline with
glycerol as a cryoprotectant (8 g/L sodium chloride, 0.2 g/L potassium chloride, 1.44 g/L
disodium phosphate, 0.24 g/L monopotassium phosphate, 100 mL/L glycerol, pH 7.3) in ratio
1:9 (w/v) for 4 min. The slurry was filtered with a filtra bag (Filtra-Bag, Thomas Scientific, New
Jersey, USA), divided into 15 mL aliquots in an anaerobic chamber (Bactron X, Sheldon
manufacturing, Cornelius, OR, USA, containing 5% H2, 5% CO2, and 90% N2), and stored at 80 °C until further use.
2.3.8. In vitro fermentation
The in vitro fermentation was performed as described by Yang et al. (2013) with slight
modifications. Fermentation media was prepared with the peptone removed (to be replaced with
digested protein isolates) and varying concentrations of carbohydrates to simulate HDF and LDF
conditions. The medium contained (per L): yeast extract (2 g, Fisher Scientific, Waltham, MA),
bile salts (0.5 g, Oxoid, Cheshire, England), sodium bicarbonate (2 g), sodium chloride (0.1 g),
dipotassium phosphate (0.08 g), magnesium sulfate heptahydrate (0.01 g), calcium chloride
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dihydrate (0.01 g), L-cysteine hydrochloride (0.5 g, Fisher Scientific, Waltham, MA), hemin (1
mL, 5 mg/mL dissolved in DMSO), Tween 80 (2 mL, Fisher Scientific, Waltham, MA), vitamin
K solution (10 μL dissolved in ethanol, Alfa Aesar, Haverhill, MA), 0.025% (w/v) resazurin
solution (4 mL dissolved in water, Alfa Aesar, Haverhill, MA). A mixture of soluble
carbohydrates were added to the media to simulate a range of fibers present in a typical diet:
soluble starch (S9765, Sigma, St Louis, MO, USA), inulin (Orafti HP, BENEO, Mannheim,
Germany), arabinogalactan (A1328, TCI, Tokyo, Japan), xylan (X0064, TCI, Tokyo, Japan), and
pectin (J6102, Alfa Aesar, Haverhill, MA) (Aguirre et al., 2016a; Venema & van den Abbeele,
2013). The carbohydrates were added at equal concentrations of 0.2 g/L and 2 g/L for total
carbohydrate concentrations of 0.1% and 1% in the LDF and HDF media, respectively. The
volume was adjusted to 1 L and the pH to 6.8 before autoclaving for sterilization.
The in vitro fermentation was completed in 20 mL glass vials (SU860030, Supleco,
Bellefonte, PA, USA) with 18 mm screw cap (SU860101, Supleco, Bellefonte, PA, USA).
Protein isolates, freeze-dried after in vitro digestion, were added at varying weights (99.5 g –
156.8 mg) to adjust to a constant total nitrogen concentration (1%) and suspended in 9 mL
fermentation media. A blank sample was prepared with an absence of freeze-dried digested
protein isolate. Vials were inoculated with 1 mL of fecal slurry and incubated at 37 °C in the
anaerobic chamber. Three mL samples were collected at 0, 8 and 24 h, with the 0 h being taken
immediately after inoculation. All samples were stored at -80 °C until further analysis.
2.3.9. Microbiome Composition
DNA extraction was completed with the BioSprint 96 One-For-All Vet Kit (SP947057,
Qiagen, Germantown, MD, USA). One mL aliquots of the fermentation slurries were centrifuged
and the pellets were resuspended in 400 µL of warmed ASL stool lysis buffer (19082, Qiagen,
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Germantown, MD, USA) and the manufacturer’s protocol was followed. Extracted DNA
samples were subjected to amplicon sequencing of the V4 region of the 16S rRNA gene on the
Illumina MiSeq platform using the MiSeq reagent kit v2 (2 x 250 bp) (Kozich et al., 2013). Prior
to sequence analysis using the QIIME 2 platform, sequences were demultiplexed and barcodes
were removed (Bolyen et al., 2019). Next, DADA2 was used to perform sequence quality
control, trimming, chimera removal and denoising (Callahan et al., 2016). To maintain sequence
qualities above a phred score of 30, forward and reverse reads were truncated to 245 and 160 bp,
respectively. With DADA2, sequences were dereplicated into 100% ASVs for exact sequence
matching and taxonomy was assigned using the SILVA database (Quast et al., 2012).
2.3.10. Peptide Quantification
The concentration of peptides in samples during fermentation was measured by Pierce
Quantitative Fluorometric Peptide Assay kit (23290, Fisher Scientific, Waltham, MA, USA). The
supernatant from fermentation slurry after the centrifugation during DNA extraction was diluted
50-fold with distilled water. Next, 10 µL of each diluted sample was transferred into a 96-well
fluorometric compatible plate (88378, Fisher Scientific, Waltham, MA, USA). The
manufacturer’s instructions were followed and peptide concentration of each fermented sample
was determined based on a calibration (7.8-1000 µg/mL) with the addition of a blank.
2.3.11. Short chain and branched chain fatty acids
SCFA and BCFA were extracted from the supernatant of the fermentation slurry and
measured by gas chromatography as described by Hartzell et al. (2013). First, 0.4 mL of
fermentation supernatant, 0.1 mL of 7 mM 2-ethylbutyric acid in 2 M potassium hydroxide, 0.2
mL of 9 M sulfuric acid, and 0.16 g of sodium chloride were mixed together. Next, 0.5 mL of
diethyl ether was added and vortexed for 30 s. The diethyl ether top layer was injected into the
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gas chromatograph (Clarus 580, PerkinElmer, MA USA) with capillary column (Elite-FFAP, 15
m × 0.25 mm inner diameter × 0.25 μm film thickness, PerkinElmer, Waltham, MA, USA) and
the SCFAs were detected by a flame ionization detector at 240 °C. SCFAs were quantified by
calculating response factors for each SCFA relative to the 2-ethyl butyric acid internal standard.
2.3.12. Ammonia
Determination of ammonia in fermentation samples was performed as described by
Solòrzano (1969). One mL of fermentation supernatant was diluted 100-fold with distilled water
and the ammonia concentrations were determined by a standard curve with ammonium chloride
standards (1-10 mg/L).
2.3.13. NMR Metabolomics
Preparation of fecal slurry samples was performed as described by Boulaka et al. (2020)
with slight modifications. Four hundred and fifty microliters of fermentation slurry supernatant
was evaporated to dryness using a centrifugal concentrator (SpeedVac, Fisher Scientific,
Waltham, MA, USA), followed by consecutive pellet washes of 500 µL of 100% methanol, 50%
methanol and water. The three washes were combined for a total volume of 1.5 mL and
evaporated to dryness overnight. Samples were reconstituted in 550 µL of 50 mM phosphate
buffer (pH 7.2) prepared in D2O spiked with 50 μM 3-(trimethylsilyl) propionic-2,2,3,3-d4 acid
sodium salt (TMSP-d4) as an internal reference standard. The 1D 1H NMR spectra were acquired
using Topspin version 3.5 on a Bruker AVANCE III-HD 700 MHz spectrometer equipped with a
5 mm quadruple resonance QCIP cryoprobe (1H, 13C, 15N, and 31P) with z-axis gradients. A
SampleJet automated sample changer system, an automatic tune and match system (ATM), and
ICON-NMR software was used to automate the NMR data collection. The 1D 1H NMR spectra
was collected with an excitation sculpting pulse sequence for solvent suppression. The 1D 1H
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NMR spectra was collected at 298 K with a spectral width of 9803 Hz, 64K data points, 128
scans, 4 dummy scans, and relaxation delay of 1s. Spectra were Fourier transformed,
automatically phased, and baseline corrected. Chemical shifts and metabolite quantification were
referenced to the TMSP-d4 peak at δ=0.00 ppm. Metabolite concentrations were determined by a
standard curve with the corresponding metabolite standard prepared in fermentation media (1251000 µM).
2.3.14. Statistical analysis
For protein concentration of isolates pre- and post-digestion, a t-test was preformed to
determine significant differences between animal and plant protein isolates on three technical
replicates of each protein isolate.
Normalizing, filtering, and diversity calculations of the 16s rRNA sequencing data were
performed using the phyloseq package (McMurdie & Holmes, 2013) in R (version 4.1.2) and
RStudio (2022.02.3). Samples with less than 5000 reads were removed (3 samples) and then
sample reads were normalized to the median sequencing depth of 20,151 reads. Taxa from
Archaea and ASVs (<0.1% in all samples or <20 reads across all samples) were removed and
ASVs were merged by genus after diversity calculations and before statistical analysis.
Linear discriminate analysis effect size (LEfSe) analysis from Galaxy/Hutlab (Segata et
al., 2011) identified differentially abundant features of the microbiome after 24 h of in vitro
fermentation under LDF and HDF conditions. Protein isolate was defined as the class variable,
and a Kruskal-Wallis test analyzed all features to determine whether the values in different
classes are differentially distributed. Microbiome was defined as the subclass variable and a
pairwise Wilcoxon test analyzed comparisons between microbiomes. With an LDA effect size >
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2 and p < 0.05, significant differences at the phylum-, class-, order-, family- and genus-level
were identified.
For β-diversity, non-metric multidimensional scaling (NMDS) of Bray-Curtis distances
across all subjects and by individual subjects were completed. In the NMDS analyses by subject,
it was apparent that fermentation time was the primary variable responsible for variation in
NMDS1 and fiber condition was the primary variable responsible for variation in NMDS2.
Therefore, Wilcoxon’s test was used to determine significant differences between NMDS scores
for fermentation time and fiber condition with a Bonferroni p-value correction for multiple
comparisons (for time).
For the metabolites, two ANOVA models were run on log-transformed data using R.
First, a full model was run with all four experimental design factors and interactions (‘Subject
habitual diet’, ‘Fiber condition’, ‘Protein’, and ‘Time’) and ‘Microbiome’ nested within ‘Subject
habitual diet’. ‘Protein’ was modelled as a stand-alone variable rather than nesting it within
‘Protein category’ because we wanted to examine differences across all protein isolates rather
than just differences among proteins within the plant or animal protein categories. For most
metabolites, all or nearly all of the three and four-way interactions among variables were
significant and ‘Microbiome’ within ‘Subject habitual diet’ was significant. Therefore, twofactor ANOVAs using ‘Protein’ and ‘Time’ as factors were run by ‘Microbiome’ and ‘Fiber
condition’ to examine the differences among protein isolates during fermentation within
microbiome and fiber condition. For all ANOVAs, 0 h was removed from the ‘Time’ variable
because there was no effect of protein isolate yet at a fermentation time of 0 h. Tukey’s HSD test
was used to determine significant differences among the main effect of ‘Protein’ in the two-
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factor ANOVAs. All data was plotted in R using the ggplot2 and cowplot packages (Wickham,
2016; Wilke, 2019).
To determine correlations between amino acid concentrations and metabolite production
under LDF conditions, partial Spearman correlation coefficients were calculated using SAS
software (version 9.4, Cary, NC USA) on mean data at 0 h (amino acids) and 24 h (metabolites)
of fermentation. The correlations were performed with the partial variables, ‘Microbiome’ and
‘Protein’. The correlation coefficients were visualized in a clustered heatmap using the
ComplexHeatmap package in R (Gu et al., 2016).
2.4. RESULTS
2.4.1. Subject Selection
Microbiomes used in this study were selected from among thirty prospective stool donors
based on dietary history of animal and plant protein (Table 2.1). Donors 259 and 318 were
identified as consuming most of their protein from animal sources (Table 2.1). In contrast,
donors 148 and 403 were identified as consuming a majority of their protein from plant sources.
Donors with high plant protein intake (148, 403) consumed more protein from legumes, nuts,
and seeds. Milk intake did not separate animal and plant protein consumers, with donor 148—a
high plant protein consumer—and 259—a high animal protein consumer—tending to consume
more milk than the other stool donors. The plant-protein consumers (148, 403) had a diet higher
in fiber compared to subjects 259 and 318.
2.4.2. Substrate Characterization
The three animal proteins (beef, milk, egg white) and three plant proteins (pea and two
soy) all contained > 85% protein and were not significantly different in protein concentration
(Table 2.2). The plant protein isolates showed similarities in amino acid profiles, while the
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animal protein isolates differed in the concentration and distribution of amino acids in both
nondigested and digested samples (Figure 2.1). Plant proteins had high concentrations of
glutamate, arginine, lysine, and aspartic acid. For animal proteins, beef had high concentrations
of glycine and proline; egg white had high concentrations of cysteine and methionine; and
glutamate, proline and lysine were higher in milk protein.
The plant protein isolates showed a wide range of proteins with differing molecular
weights, while the animal protein isolates lacked in protein diversity (Figure 2.2 A). The
molecular weight profiles showed that egg white protein isolate was very different from the other
protein isolates (Figure 2.3 A). Additionally, milk protein isolate was similar to the soy proteins,
while the beef protein isolate was similar to the pea protein isolate.
To prepare proteins for in vitro fermentation, samples were subjected to in vitro digestion
followed by exhaustive dialysis to remove digested amino acids and peptides < 1 kDa. The SDSPAGE gel of the digested and dialyzed protein isolates confirmed extensive digestion of proteins
into peptides except for the egg white, which still contained bands corresponding to the major
intact proteins (Figure 2.2 B). This was reflected in the size-exclusion chromatography, which
showed that the peptides with molecular weights greater than 7000 Dalton was > 90% for egg
white protein isolate (Figure 2.3 B). However, the percentage of peptides with molecular weights
greater than 7000 Dalton ranged from 38% to 56% for the other protein isolates. The clustering
of the protein isolates after digestion was similar to before digestion, except Soy1 moved from
the cluster with milk protein isolate to the cluster with beef and pea protein isolates (Figure 2.3
B).
2.4.3. Fermentation Metabolites
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Under HDF conditions, the total peptides showed little change in concentration over the
course of fermentation (0 h to 24 h) (Figure 2.4). In contrast, under LDF conditions, total peptide
concentrations declined over the 24 h period for some protein isolates (Figure 2.4). This
demonstrates that the microbiomes were primarily saccharolytic under HDF conditions,
neglecting the metabolism of peptides. However, under LDF conditions, the microbiome utilized
the peptides due to the lack of available fiber. Across all four microbiomes, milk protein had
significantly higher total peptides available, while the egg white protein had significantly lower
total peptides than the other protein isolates.
Gut fermentation metabolite production varied by microbiome (Figures 2.5-2.12). The
full ANOVA results indicated a significant difference in metabolite production based on habitual
diet; however, additional interactions suggest that individual subjects within habitual diets are
significantly different (Table 2.3). For acetate, propionate, and total SCFA, production was not
consistent among microbiomes and protein isolates (Figures 2.5-2.7). However, surprisingly,
butyrate production was higher and there was greater variation among proteins under the LDF
condition compared with the HDF condition (Table 2.3; Figure 2.8). In addition, higher butyrate
production was associated with milk compared to the other proteins, even under HDF (Figure
2.8). Second to milk protein, soy protein tended to result in high butyrate production in most
microbiomes. This indicates that the metabolism of protein isolates can result in consistent
differential production of butyrate among microbiomes.
The LDF condition showed an increase in iso-valerate, iso-butyrate, and total BCFA,
production (Table 2.3; Figures 2.9-2.11). In addition, milk protein and either of the soy proteins
consistently resulted in higher concentrations of BCFAs compared to the other protein isolates.
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Ammonia production increased under LDF (except for subject 148) compared to HDF
(Table 2.3; Figure 2.12). The three plant protein isolates together with milk protein tended to
result in more ammonia compared to beef and egg white under LDF (expect microbiome 148).
Cadaverine, a metabolite of lysine, production was greater under HDF conditions than
LDF conditions (Table 2.3; Table 2.4). Soy, pea and milk protein isolates consistently resulted in
high cadaverine concentrations. Milk protein tended to result in more 4-hydroxyphenylactetae, a
metabolite of tyrosine, across microbiomes compared to the other protein isolates (Table 2.5).
2.4.4. Microbiome composition
Non-metric multidimensional scaling (NMDS) of Bray-Curtis dissimilarity index showed
major clustering by microbiome and clustering by time within microbiomes (Figure 2.13 A).
Additionally, high plant intake microbiomes (148 and 403) had smaller NMDS1 values and high
animal intake microbiomes (259 and 318) had larger NMDS2 values indicating grouping based
on dietary habit. When β-diversity was run by microbiome, variation among samples was
attributed to the effect of time (NMDS1) and dietary fiber condition (NMDS2) (Figure 2.13 B).
The Shannon index showed a drop in α-diversity over time in both HDF and LDF conditions
(Figure 2.14). Consistently, the blank (no protein) was higher in α-diversity, while in a few
instances, egg white protein was tended to be lower compared to the other protein isolates.
Linear discriminant analysis effect size (LEfSe) analysis at 24 h with protein isolate as the
class variable and microbiome as the subclass variable under HDF showed that the protein
isolates did not induce differential changes in the microbiome (Figure 2.15 A). However, under
LDF conditions, LEfSe analysis showed that the milk protein induced phylum-level changes in
the microbiome (Figure 2.15 B). Compared with the other protein isolates and the blank, the milk
protein resulted in increased abundance of Clostridia from the Firmicutes phylum. At the family
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phylogenetic level, Lachnospriaceae, Oscillospiraceae, and Sutterellaceae were significantly
associated with milk protein. Several other protein isolates were significantly associated with
other families: Coriobacteriaceae, Lactobacillaceae, and Leuconosctocaceae with pea protein;
Marianifilaceae and Butyricicoccaceae with Soy1; and Tannerellaceae with beef protein.
LEfSe analysis also revealed several genera that were associated with different protein
isolates. When the abundances of these genera at 24 h of fermentation in the LDF condition were
plotted by microbiome, the milk and pea proteins clustered separately from the other protein
isolates (Figure 2.16). Milk protein was significantly associated with Flavonifractor,
Intestinimonas, Colidextribacter, and UCG-002, all of whom belong to the Oscillospiraceae
family, and Adlercreutzia, Negativibacillus, and Parasuttterella. Additionally, Soy1 was
significantly associated with Uncl_Lachnospiraceae and Butyricicoccus, while Soy2 was
associated with Lachnoclostridium. This indicates that the protein isolates, regardless of animal
or plant origin, all induced unique shifts on the microbiome composition at the phylum, class,
order, family and genus phylogenetic level. Some proteins, specifically milk, showed more
significant features of the microbiome compared to other protein isolates.
2.4.5. Partial Correlations
Pearson partial correlations between metabolite production of LDF samples and amino
acid concentrations in the digested protein isolates indicated a significant positive correlation
between butyrate production and glutamate and proline concentrations across all proteins (Figure
2.17). In addition, glutamate was significantly correlated with total SCFA and BCFA, while
proline was correlated with total SCFA (p < 0.05). On the other hand, phenylalanine and aspartic
acid indicated a negative correlation with butyrate production (p < 0.05). Cadaverine production
was only positively associated with lysine. The amino acid profile of protein isolates can be
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associated with total SCFA and butyrate production, in addition to total BCFA and cadaverine,
proteolytic fermentation metabolites.
2.5. DISCUSSION
The microbiome preferentially ferments dietary carbohydrates, but when there is a lack of
dietary carbohydrates available, the microbiome can metabolize proteins for energy (Yao et al.,
2016). Fiber fermentation produces primarily beneficial SCFA, and, while protein fermentation
also produces SCFA, it also generates harmful metabolites that can have a negative influence
host health (Macfarlane & Macfarlane, 2012; Vinolo et al., 2011; Yao et al., 2016). The present
research aimed to understand how different protein isolates affect gut microbiota composition
and function in response to HDF or LDF conditions. An in vitro fermentation with enzymatically
digested animal and plant protein isolates was completed with four microbiomes differing in
habitual diet and two fermentation medias with differing carbohydrate concentrations to mimic
LDF and HDF conditions. Metabolite production and microbiome composition were analyzed to
determine the microbial response to the protein isolates under differential fiber conditions.
Dietary fiber condition influenced the utilization of protein isolates by the microbiota.
Under HDF conditions, gut microbes did not metabolize the available proteins and peptides, as
indicated by a stable concentration of peptides during fermentation, presumably because of the
abundant available carbohydrate. However, under LDF conditions, there was a decrease in
peptide concentrations during fermentation, indicating that the microbiome was forced to
metabolize the protein isolates for energy. Proteins and peptides are energetically favored for
anabolic biosynthesis rather than catabolism (Oliphant & Allen-Vercoe, 2019). Both in vitro
(Aguirre, Eck, et al., 2016; Smith & Macfarlane, 1998) and human studies (Cummings et al.,
1979; Geypens et al., 1997; Russell et al., 2011) have shown that the presence of fiber reduces
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peptide metabolism and accompanying proteolytic metabolites. Because under HDF conditions
the microbiomes metabolized carbohydrates and not peptides, there were no differences in
microbial response to the different digested protein isolates supplied. Only under the LDF
conditions were differentially abundant microbiome features and consistent variations in
metabolite concentrations evident due to protein isolate.
Prior to fermentation, the raw materials and digested protein isolates were analyzed for
amino acid composition and molecular weight distribution. These analyses indicated that the
plant proteins were very similar in composition while the animal protein isolates were distinct.
Our amino acid profiles were consistent with other findings in research. Gorissen et al. (2018)
previously reported similarities of commercially available plant-based protein isolates regarding
low methionine concentrations and high glutamic acid and lysine concentrations.
The amino acid profile can influence amino acid specific fermentation metabolites
including the production of phenols (tyrosine), indoles (tryptophan), cadaverine (lysine), 4aminobutyrate (arginine) and hydrogen sulfide (methionine and cysteine) (Diether & Willing,
2019; Oliphant & Allen-Vercoe, 2019; Windey et al., 2012). Thus, because plant proteins shared
similar composition and animal proteins were more different, we anticipated that the plant
protein isolates would impart similar fermentation profiles and the animal protein isolates would
show different fermentation patterns. Instead, we found milk protein produced higher
concentrations and more similar to the plant proteins, especially soy protein, compared to the
animal protein isolates.
Research on dietary fibers has shown that chain length of certain carbohydrates can
influence microbial metabolism because some species are unable to grow on long chain
polysaccharides (Falony et al., 2009; Flint et al., 2012; Rossi et al., 2005). Thus, the chain length
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of peptides may be responsible for the similarities among protein isolates with distinct amino
acid profiles. It is well documented that Escherichia coli can only uptake small peptides less than
650 Da, while Lactococcus lactis and Bacillus megaterium can take up peptides more than 2,140
and 10,000 Da, respectively (Walker & Altman, 2005). However, there is a lack of research
indicating the impact of the peptide length on the microbiota composition. Such a topic is worthy
of investigation; however, due to minimal variation in molecular weight profiles, accompanied
by different compositions among the protein isolates, this study was not designed to examine this
effect.
Careful attention was paid to the selection of microbiomes to use in this study. We
selected four donors with contrasting protein intakes (two with high plant protein intakes and two
with high animal protein intakes) from among 30 potential stool donors. We anticipated that
habitual dietary habits of the stool donor would influence the utilization of fiber and protein
isolates during in vitro fermentation due to the microbial communities present. Microbiomes
from subjects with a high plant protein and fiber diet typically contain more saccharolytic
organisms, favoring carbohydrate fermentation, while subjects consuming a diet high in animal
protein and low in fiber contain more proteolytic organisms (De Filippo et al., 2010). The
grouping by habitual diet in the β-diversity plots emphasized the unique microbial communities
present based on habitual protein consumption. In addition, the ANOVA results indicated a
significant difference in metabolite production, mostly proteolytic metabolites, based on habitual
diet. Similarly, Yang & Rose (2014) and Yang & Rose (2016) found through an in vitro model
that a habitual diet influenced metabolite production with the fermentation of whole wheat
substrate and inulin, respectively. On the other hand, another study found no difference in the
utilization of individual amino acids and ammonia production using fecal samples from
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vegetarians and omnivorous donors (Richardson et al., 2013). While subject habitual diet
significantly influences metabolite production, within the habitual diets, the microbiomes are
significantly different indicating a lack of consistent grouping. To conclude if long-term dietary
habits influence the utilization of fiber and protein isolates during fermentation, additional
microbiomes would need to be added to the study.
In human feeding studies, when there is more fiber available, greater concentrations of
total SCFA are produced with potential variation among individual SCFAs (David et al., 2014;
Russell et al., 2011). However, fermentation of peptides and amino acids can be a substrate for
SCFA production. Glycine, threonine, and glutamate are metabolized to acetate, while lysine,
glutamate, and tryptophan breakdown can produce butyrate (Neis et al., 2015). And Davila et al.
(2013) reported that propionate is primarily produced from alanine and threonine metabolism.
Therefore, while SCFAs are expected to increase with fiber, SCFAs are the main bacterial
product of protein metabolism and are influenced by the amino acid profile (Rios-Covian et al.,
2020).
As expected, total BCFA and ammonia production were greater under LDF conditions
compared to HDF conditions. Under LDF, the microbiome was forced to metabolize peptides,
and therefore, produced greater concentrations of these amino acid-specific metabolites. These
findings are supported by Aguirre et al. (2016b), who found using an in vitro model that highprotein conditions increased BCFA production, while a high carbohydrate conditions reduced
BCFA production. For ammonia production, Vince et al. (1990) incubated fecal samples with
added lactulose, pectin, arabinogalactan and cellulose at a final concentration of 10 g/L, both
before and after subjects had been fed each individual carbohydrate. Compared to a control
fermentation (no additional carbohydrate), pectin and arabinogalactan decreased ammonia
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production when the subjects were fed these substrates prior to fecal collection. Additionally,
lactulose significantly decreased ammonia production regardless of if the subjects were fed one
of the fibers prior to in vitro fermentation. There is little research surrounding the health effects
of BCFA production. However, high levels and sustained exposure to ammonia can harm
colonocytes by decreasing proliferation and causing DNA damage (Diether & Willing, 2019;
Rowland et al., 1998). These studies and ours confirm that the presence of fibers during
fermentation reduce the production of BCFA and ammonia production, with expected positive
influences host health.
Cadaverine, a metabolite of lysine metabolism, was significantly associated with lysine
concentration across all proteins at 24 h and the proteins with higher lysine concentrations (i.e.,
plant proteins and milk) saw higher concentrations. Gorissen et al. (2018) reported that milk
protein has high levels of lysine, while soy and pea have high concentrations when compared to
other plant protein isolates. Cadaverine is a poorly studied fermentation metabolite, but has the
ability to be toxic at high levels (del Rio et al., 2019; Oliphant & Allen-Vercoe, 2019).
Cadaverine has been associated with increased cardiac output, hypotension, and bradycardia
(Shalaby, 1996; Til et al., 1997).
The protein isolates induced unique shifts in microbiota composition and metabolite
production under the LDF conditions. Most strikingly was the butyrate production during
fermentation of milk protein. The increase in butyrate production was due to increased
abundance of several genera within the Firmicutes phylum and Clostridia class which house
known butyrate producers. Seven genera were significantly associated with milk protein across
all microbiomes. Most of these genera (Flavonifractor, Intestinimonas, Colidextribacter, UCG002) belonged to the Oscillospiraceae family. Most genera capable of butyrate production are
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associated with the breakdown of carbohydrates and have enzymes for the conversion of acetate
and acetyl-CoA to butyrate (Vital et al., 2017). However, the glutarate, 4-aminobutyrate, and
lysine pathways are associated with butyrate production from amino acid metabolism (Louis &
Flint, 2017; Vital et al., 2014). Therefore, the utilization of lysine, glutamate, tryptophan, and
their amino acid derivatives can produce butyrate. Flavonifractor can produce butyrate through
the acetyl-CoA pathway as well as through metabolism of glutamate to 4-aminobutyrate and
lysine pathways (Vital et al., 2017). Through human studies, Flavonifractor has been linked to
butyrate production with a diet rich in nuts, legumes, and fiber (Rosés et al., 2021), and is
associated with a lean host phenotype (Kasai et al., 2015). However, Flavonifractor has also
been shown to be elevated in subjects consuming a high dairy diet (Khorraminezhad et al.,
2021).
In addition to amino acid metabolism, Flavonifractor can metabolize flavonoids and
yield similar fermentation metabolites. Hydroxyphenylacetic acids can be a product of microbial
metabolism of tyrosine in addition to plant secondary metabolites. While unsubstituted phenol
compounds have negative health effects (e.g., phenol and p-cresol) (Windey et al., 2012; Yao et
al., 2016), substituted phenols, including hydroxyphenylacetic acids, biological effects have been
explored little. However, because of these compounds phenolic nature, it is believed they protect
against oxidative stress (Scalbert et al., 2002). Milk protein resulted in significantly higher 4hydroxyphenylacetate, followed by the plant proteins. With an in vitro model, Lin et al. (2016)
showed that the microbiota broke down polyphenols into a series of phenolic acid metabolites,
with 4-hydroxyphenylacetate identified as a main metabolite. They confirmed the results in vivo
where they administered purified flavonoids to control and antibiotic-treat mice to evaluate
metabolism. Interestingly, researchers identified 4-hydroxyphenylacetate at low concentrations
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in samples from antibiotic-treated mice indicating phenolic acids can be produced from
metabolism routes outside of polyphenols. While protein fermentation can produce unsubstituted
phenols and indoles, similar antioxidant compounds found in flavonoid fermentation can be a
metabolism product. In addition to SCFA production, hydroxyphenylacetic acids can be a host
beneficial metabolite from proteolytic fermentation.
Flavonoid and protein fermentation result in similar phenolic compounds and degraders:
Flavonifractor and Intestinimonas (Rodriguez-Castaño et al., 2020). Flavonifractor species (F.
plautii) was closely related (>94.5% similarity for 16S rRNA sequence) to an Intestinimonas (I.
butyricproducens), which both contain the specific acetoacetyl-CoA transferase responsible for
the lysine pathway (Bui et al., 2016; Kläring et al., 2013). Intestinimonas species can metabolize
lysine to produce butyrate (Bui et al., 2015). Bui et al. (2020) used lysine in serial dilutions of
stool samples to enrich for lysine degrading species. After the second lysine enrichment, butyrate
was a major end product, with the majority of the bacteria belonging to a number of
Intestinimonas spp. Therefore, the differential abundance of Flavonifractor and Intestinimonas in
milk protein samples can be linked to significantly higher butyrate production.
Second to milk proteins, the soy proteins resulted in consistently elevated butyrate
production during in vitro fermentation. However, the soy proteins were associated with different
butyrate-producing genera than the milk proteins including, an uncultured genus and
Lachnoclostridium from the Lachnospriaceae family, and Butyricicoccus (Ruminococcaceae
family). Through a pooled analysis of over 2,000 metagenomic samples, Vital et al. (2017)
identified seventeen taxa, belonging to the Lachnospriaceae and Ruminococcaceae families, that
were present in the majority of the samples (>70%) and encompass 85% of a subjects total
butyrate-producing potential.
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Across all proteins, there was a significant positive correlation between butyrate
production and two amino acids: glutamate and proline. As previously mentioned, glutamate and
lysine can be utilized by butyrate-producing proteolytic genera. Concerning the amino acid
profile, milk had the highest concentration of glutamate and the second-highest concentration of
proline, behind beef protein. Both amino acids are greater in the plant and milk proteins than in
beef and egg white. In addition, the metabolism of tryptophan leads to butyrate production;
however, through hydrolysis, tryptophan was destroyed. Therefore, assumptions can be made
about the tryptophan concentration in the milk protein isolate because research suggests milk
proteins are particularly rich in tryptophan (Nongonierma & FitzGerald, 2015). The high
concentrations of amino acids associated with butyrate-producing pathways can help explain the
butyrogenic nature of milk and soy proteins.
While there was significant butyrate production associated with protein isolates, there
was also high levels of ammonia and cadaverine produced during protein fermentation.
Therefore, while butyrate production is a beneficial metabolite that contribute to host health, the
additional formation of negative fermentation metabolites can be a drawback. This trend was
seen across all protein isolates; however, milk was consistently producing high concentrations of
ammonia and cadaverine. Additionally, milk protein consistently had higher formation of
BCFAs which are indicative of proteolytic fermentation. The unique butyrogenic of properties of
milk protein are important, but they should not be overshadowed by the production of proteolytic
fermentation metabolites with potentially negative health effects.
In conclusion, the in vitro fermentation of protein isolates under LDF conditions showed
greater protein metabolism than HDF conditions. Under the LDF conditions, the protein isolates
were surprisingly butyrogenic, particularly milk protein and to a lesser extent soy proteins.
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However, fermentation of these protein isolates were also accompanied by elevated
concentrations of harmful metabolites such as ammonia and cadaverine. Across all proteins,
glutamate was significantly associated with butyrate production, and lysine was significantly
associated with cadaverine. The milk and soy proteins did induce increases in some beneficial
gut microbes, including Flavonifractor and Intestinimonas (milk) and uncultured genus from the
Lachnospriaceae family, Butyricicoccus, and Lachnoclostridium (soy). This information can be
used to better understand how the microbiome utilizes protein isolates under LDF conditions and
how proteins influence the production of beneficial, butyrate, and harmful proteolytic
metabolites.
Future directions of this project include completing a similar experimental design, but
focus on the digestibility of the individual protein isolates. Plant and animal proteins differ in
digestibility; however, this was not accounted for in the current experimental design. After in
vitro digestion, the digestibility would be measured and used to determine the amount of protein
isolate added to the in vitro fermentation. Therefore, protein isolates that are less digestible
would have more peptides available in the fermentation which could influence microbial
response. Additionally, an additional next step could be focusing on the milk protein, and its
associated butyrogenic response in the microbiome. An ammonium sulfate protein precipitation
can separate proteins based on solubility at differing salt concentrations (e.g. 20%, 40%, 60%,
and 80%) (Duong-Ly & Gabelli, 2014). Salting out removes hydrophobic proteins from
hydrophilic proteins; therefore, lower concentrations of salt will contain proteins composed of
more hydrophobic amino acids. Next, an in vitro fermentation would be completed with the
fractions to determine the microbial response, and potential butyrate production, caused by the
fractions.
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Table 2.1. Dietary intake, expressed per 1000 kcal, of the four selected stool donors.

Dietary Intake
Animal Protein
(g/1000 kcal)
Vegetable Protein
(g/1000 kcal)
Beef (oz/1000 kcal)
Eggs (oz/1000 kcal)
Milk (oz/1000 kcal)
Legumes (oz/1000
kcal)
Nuts and seeds
(oz/1000 kcal)
Fiber (g/1000 kcal)
Whole grain (oz/1000
kcal)
Refined grain
(oz/1000 kcal)
Fruits (cups/1000
kcal)
Vegetables (cups/1000
kcal)
1

2

Range1
12.75 – 48.32
9.20 – 26.48

26.48

23.78

9.97

11.42

0.01

0.00 – 2.20
0.04 – 1.98
0.06 – 2.54
0.00 – 1.34

0.16
0.05
1.83
0.78

0.09
0.23
0.27
1.10

0.65
0.42
2.54
0.02

1.47
0.43
0.43
0.18

0.15
0.09
0.77
0.04

0.00 – 1.31

1.24

1.31

0.49

0.17

0.03

6.20 – 16.64
0.00 – 2.55

16.64
2.55

16.19
1.02

6.49
0.24

9.52
0.80

0.03
0.26

0.35 – 3.42

1.47

2.59

1.22

1.05

0.25

0.07 – 1.12

0.31

0.75

0.32

0.43

0.56

0.15 – 1.90

1.11

0.55

0.77

0.88

0.99

Among 30 potential stool donors
t-test

P-value2
(Animal
vs Plant)
0.01

Stool donor
Plant stool donor
Animal stool donor
148
403
259
318
16.53
12.75
42.81
46.33
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Table 2.2. Protein concentration (%) of nondigested and digested protein isolates determined on
the nitrogen content multiplied by 6.25 as the standard conversion factor. Error shows standard
deviation (n=3).
Protein Concentration (%)
Protein
Source
Nondigested
Digested
Beef
Animal
98.85±0.05
87.12±3.39
Egg white
Animal
83.80±0.16
100.0±1.24
Milk
Animal
83.97±0.10
78.33±11.92
Pea
Plant
81.88±0.17
63.43±7.90
Soy1
Plant
89.90±0.04
85.16±2.90
Soy2
Plant
85.52±0.16
93.01±2.99
Mean
Animal
88.9±7.48
88.7±11.5
Mean
Plant
85.8±3.48
80.5±14.0
P-value1 (Animal vs Plant)
0.28
0.20
1
P-value = nonsignificant difference between animal and plant protein isolates using t-test
(p>0.05).
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Table 2.3. Mean squares of full ANOVA results.
Source

df

Peptides

Acetate

SubjectDiet

1

Protein

5

Medium

1

SubjectDiet*Subject

2

0.0114
1.41
***
0.539
***
0.102
***

0.0264
1.02
***
2.16
***
0.779
***

SubjectDiet*Protein

5

SubjectDiet*Medium

1

Protein*Medium

5

0.0032
0.0553
***
0.0545
***

SubjectDiet*Time

1

Protein*Time

5

0.0377
0.114
*
0.2
***
0.163
**
0.316
***
2.76
***
0.0705
***

Medium*Time

1

SubjectDiet*Protein*Subject

10

SubjectDiet*Medium*Subject

2

SubjectDiet*Protein*Medium

5

SubjectDiet*Time*Subject

2

SubjectDiet*Protein*Time

5

SubjectDiet*Medium*Time

1

0.0073
0.021
***
0.61
***
0.022
***
0.0387
***
0.0076
*
0.0345
***

Protein*Medium*Time

5

SubjectDiet*Protein*Medium*Subject

10

SubjectDiet*Protein*Time*Subject

10

SubjectDiet*Medium*Time*Subject

2

0.0058
0.0604
***
0.0354
***
0.0098
***
0.0122
***
0.0224
***

SubjectDiet*Protein*Medium*Time
SubjectDiet*Protein*Medium*Time*
Subject
Error

5

0.0054

10
188

0.0048
0.003

*p<0.05; **p<0.01; ***p<0.001

0.0343
0.164
***
0.425
***
0.0557
*
1.86
***
0.256
***

Propionate
0.903
***
0.489
***
7.07
***
1.88
***
0.093
**
0.024
0.168
***
0.347
***
0.234
***
1.66
***
0.03
0.08
0.15
***
0.043
0.016
0.145
*
0.322
***

0.0321
0.0768
***
0.758
***

0.011

0.0217
0.0392
*
0.0205

0.007
0.1
***
0.03

0.042
0.058

Butyrate
0.812
*
6.6
***
11.2
***
10.8
***
0.508
**
1.31
**
0.805
***
1
**
0.143
21.5
***
0.795
***
3.02
***
0.386
*
0.863
**
0.238
1.2
**
0.895
***
0.728
***
0.681
***
0.57
*
0.325
*
0.706
***
0.134

SCFA
0.029
0.94
***
0.258
***
0.225
***
0.018
0.007
0.094
***

Isobutyrate
4.65
***
0.257
**
5.24
***
9.34
***
0.124
0.729
***
0.564
***

0.059
0.215
***
3.78
***
0.046
**
0.155
***
0.091
***
0.25
***

0.157

0.015
1
***
0.233
***

0.036

0.013
0.044
**
0.415
***
0.015
0.044
*
0.018

0.096
0.303
*
0.165
**
1.31
***
0.272
**
0.026

0.159
0.197
*
0.134
*
0.368
***
1.53
***
0.233
**
0.029
0.065

Isovalerate
2.36
***
1.39
***
17.6
***
1.55
***
0.105
*
0.68
***
0.132
**
0.29
**
0.333
***
7.15
***
0.082
*
0.111
0.03

BCFA
2.1
***
0.575
***
9.76
***
3.75
***
0.094
*
0.631
***
0.435
***
0.472
***
0.247
***
2.61
***
0.086
**
0.783
***
0.076
*

0.078
0.169
***
0.737
***

0.002

0.046

0.05
0.099
***
0.134
***
0.555
***

0.012
0.124
***
0.074
0.151
**
0.106
**
0.038

0.019
0.003

0.07
0.07
*
0.031

Ammonia
1.24
***
1.11
***
19.3
***
0.581
***
0.08
***
0.361
***
0.469
***

Cadaverine
0.329
***
1.29
***
0.19
**
0.0182

p_HPA
0.148
*
2.96
***
0.791
***
0.163
**

0.014

0.0148

0.0115
0.0514
*

0.144*
0.154
***

0.004
0.115
***
0.13
***
0.06
***
1.05
***
0.047
***
0.087
***
0.054
***
0.072
***
0.025
***
0.082
***
0.031
***
0.14
***
0.051
***
0.024
***
0.005

0.0183

0.009
0.135
***
0.657
***
0.0485
*
0.213
***

0.0232
0.0868
*
0.0995
***
0.0906
**
0.0711
**
0.0899
**
0.0069
0.0021
0.0095
0.0302
0.0423
**
0.0422
0.0212
0.0099
0.0175

0.0082
0.167
**
0.0572
*
0.102
*
0.128
***
0.0333
0.0819
***
0.161
**
0.0765
**
0.0568
*
0.0245
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Table 2.4. Cadaverine production (µM) during in vitro fermentation of protein isolates under
high dietary fiber (HDF) and low dietary fiber (LDF) by microbiome. Error shows standard
deviation (n=3).
HDF

LDF

Microbiome
Tukey
Tukey
Protein
8h
24 h
HSD*
8h
24 h
HSD*
148
Blank
c
e
134 ± 42
128 ± 17
146 ± 9
211 ± 30
Beef
b
cd
662 ± 99
1070 ± 56
530 ± 139 875 ± 262
Egg white 347 ± 120
c
de
378 ± 82
255 ± 20
540 ± 400
Milk
ab
b
950 ± 187 1478 ± 731
746 ± 188 1493 ± 264
Pea
a
a
1248 ± 5 1808 ± 502
814 ± 47 2163 ± 153
Soy1
b
a
757 ± 92 1126 ± 154
828 ± 13 2195 ± 356
Soy2
b
bc
763 ± 87
1026 ± 93
790 ± 36
1040 ± 47
403
Blank
d
e
155 ± 34
147 ± 22
169 ± 19
172 ± 64
Beef
c
c
635 ± 137 547 ± 127
725 ± 48 1155 ± 152
Egg white
cd
d
224 ± 60
685 ± 437
256 ± 28
720 ± 73
Milk
b
ab
935 ± 168 1493 ± 136
1212 ± 145 1585 ± 62
Pea
a
a
1255 ± 240 2044 ± 377
884 ± 133 2355 ± 388
Soy1
ab
ab
979 ± 86 1588 ± 248
899 ± 83 2060 ± 172
Soy2
b
b
992 ± 115 1136 ± 152
865 ± 81 1697 ± 166
259
Blank
c
b
166 ± 21
242 ± 89
556 ± 696
186 ± 6
Beef
bc
ab
740 ± 151 863 ± 124
823 ± 97 1443 ± 127
Egg white 624 ± 496
bc
ab
499 ± 59
1390 ± 775 834 ± 180
Milk
a
ab
1363 ± 419 1810 ± 658
808 ± 75 1581 ± 933
Pea
a
b
1017 ± 295 1912 ± 750
994 ± 47 1595 ± 167
Soy1
ab
ab
809 ± 201 1109 ± 65
746 ± 61 1021 ± 719
Soy2
ab
ab
919 ± 266 1069 ± 78
827 ± 310 1184 ± 793
318
Blank
d
f
122 ± 18
127 ± 4
149 ± 21
146 ± 32
Beef
c
cd
431 ± 34
737 ± 117
805 ± 169 1045 ± 22
Egg white
c
e
293 ± 25
701 ± 510
341 ± 135 656 ± 182
Milk
a
d
853 ± 56 1433 ± 224
754 ± 58 1026 ± 121
Pea
ab
a
834 ± 183
968 ± 59
992 ± 80 1876 ± 164
Soy1
bc
bc
496 ± 31
751 ± 161
912 ± 43 1313 ± 186
Soy2
bc
b
671 ± 76
789 ± 46
890 ± 68
1439 ± 80
* Proteins marked with different letters within dietary fiber condition and microbiome are
significantly different (Tukey’s HSD test p<0.05).
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Table 2.5. 4-hydroxyphenylacetate (µM) production during in vitro fermentation of protein
isolates under high dietary fiber (HDF) and low dietary fiber (LDF) by microbiome. Error shows
standard deviation (n=3).
HDF

LDF

Microbiome
Tukey
Tukey
Protein
8h
24 h
HSD*
8h
24 h
HSD*
148
Blank
d
e
65 ± 43
107 ± 27
54 ± 11
16 ± 0
Beef
cd
e
213 ± 50
177 ± 32
185 ± 67
91 ± 70
Egg white
cd
d
229 ± 87
249 ± 26
253 ± 31
250 ± 52
Milk
a
a
853 ± 155 869 ± 514
641 ± 68
885 ± 120
Pea
ab
b
525 ± 21
652 ± 123
533 ± 52
679 ± 73
Soy1
bc
c
454 ± 53
471 ± 85
391 ± 29
401 ± 30
Soy2
bc
c
483 ± 91
406 ± 16
352 ± 35
388 ± 23
403
Blank
e
e
82 ± 55
115 ± 29
80 ± 33
60 ± 38
Beef
d
e
184 ± 15
239 ± 10
161 ± 39
85 ± 28
Egg white
de
d
174 ± 15
181 ± 86
231 ± 16
303 ± 57
Milk
a
a
727 ± 22
974 ± 12
891 ± 72
901 ± 50
Pea
b
b
459 ± 129
823 ± 24
407± 40
656 ± 12
Soy1
c
c
366 ± 11
459 ± 43
343 ± 34
413 ± 30
Soy2
c
cd
366 ± 35
464 ± 39
349 ± 22
306 ± 4
259
Blank
e
d
104 ± 39
95 ± 77
97 ± 4
72 ± 14
Beef
de
cd
173 ± 9
225 ± 22
172 ± 9
64 ± 30
Egg white
cde
bc
231 ± 70
297 ± 49
149 ± 183
418 ± 66
Milk
a
a
818 ± 165 977 ± 240
844 ± 97
221 ± 146
Pea
b
ab
474 ± 163
660 ± 49
525 ± 41
271 ± 244
Soy1
bcd
bcd
348 ± 200
415 ± 40
403 ± 15
89 ± 22
Soy2
bc
ab
403 ± 32
455 ± 19
473 ± 99
227 ± 129
318
Blank
e
d
115 ± 29
132 ± 13
110 ± 29
16 ± 0
Beef
de
d
213 ± 3
169 ± 20
167 ± 29
78 ± 19
Egg white
d
b
207 ± 37
199 ± 12
402 ± 87
400 ± 95
Milk
a
a
823 ± 8
1009 ± 28
709 ± 41
914 ± 102
Pea
b
b
532 ± 43
583 ± 80
513 ± 11
357 ± 28
Soy1
c
c
315 ± 28
409 ± 66
432 ± 73
130 ±74
Soy2
c
cd
376 ± 10
379 ± 79
423 ± 58
297 ± 20
* Proteins marked with different letters within dietary fiber condition and microbiome are
significantly different (Tukey’s HSD test p<0.05).
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Figure 2.1. Amino acid profile (weight %) of (A) nondigested and (B) digested protein isolates.
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Figure 2.2. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) profile of
(A) nondigested and (B) digested protein isolates with lanes: (1) molecular markers, Pea, Soy2,
Soy1, Milk, Egg white, and Beef.
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Figure 2.3. Molecular weight (MW) distribution of (A) nondigested and (B) digested protein
isolates. Error bars show standard deviation (n=3).

70

Figure 2.4. Total peptides during in vitro fermentation of protein isolates under high dietary
fiber (HDF) and low dietary fiber (LDF) by microbiome. Error bars show standard deviation
(n=3). Letters are color-coded by protein type and proteins marked with different letters are
significantly different (Tukey’s HSD test p<0.05).
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Figure 2.5. Short-chain fatty acid (SCFA) production during in vitro fermentation of protein
isolates under high dietary fiber (HDF) and low dietary fiber (LDF) by microbiome. Error bars
show standard deviation (n=3). Letters are color-coded by protein type and proteins marked with
different letters are significantly different (Tukey’s HSD test p<0.05).
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Figure 2.6. Acetate during in vitro fermentation of protein isolates under high dietary fiber
(HDF) and low dietary fiber (LDF) by microbiome. Error bars show standard deviation (n=3).
Letters are color-coded by protein type and proteins marked with different letters are
significantly different (Tukey’s HSD test p<0.05).
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Figure 2.7. Propionate production during in vitro fermentation of protein isolates under high
dietary fiber (HDF) and low dietary fiber (LDF) by microbiome. Error bars show standard
deviation (n=3). Letters are color-coded by protein type and proteins marked with different
letters are significantly different (Tukey’s HSD test p<0.05).
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Figure 2.8. Butyrate production during in vitro fermentation of protein isolates under high
dietary fiber (HDF) and low dietary fiber (LDF) by microbiome. Error bars show standard
deviation (n=3). Letters are color-coded by protein type and proteins marked with different
letters are significantly different (Tukey’s HSD test p<0.05).
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Figure 2.9. Branched-chain fatty acid (BCFA) production during in vitro fermentation of protein
isolates under high dietary fiber (HDF) and low dietary fiber (LDF) by microbiome. Error bars
show standard deviation (n=3). Letters are color-coded by protein type and proteins marked with
different letters are significantly different (Tukey’s HSD test p<0.05).
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Figure 2.10. Isovalerate production during in vitro fermentation of protein isolates under high
dietary fiber (HDF) and low dietary fiber (LDF) by microbiome. Error bars show standard
deviation (n=3). Letters are color-coded by protein type and proteins marked with different
letters are significantly different (Tukey’s HSD test p<0.05).
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Figure 2.11. Isobutyrate production during in vitro fermentation of protein isolates under high
dietary fiber (HDF) and low dietary fiber (LDF) by microbiome. Error bars show standard
deviation (n=3). Letters are color-coded by protein type and proteins marked with different
letters are significantly different (Tukey’s HSD test p<0.05).
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Figure 2.12. Ammonia production during in vitro fermentation of protein isolates under high
dietary fiber (HDF) and low dietary fiber (LDF) by microbiome. Error bars show standard
deviation (n=3). Letters are color-coded by protein type and proteins marked with different
letters are significantly different (Tukey’s HSD test p<0.05).
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Figure 2.13. β-diversity, non-metric multidimensional scaling calculated of Bray-Curtis
dissimilarity index among (A) all samples and (B) grouped based on microbiome and separated
by axes: NMDS1 and NMDS2. *p<0.05, **p<0.01 , ***p<0.0001 (Wilcoxon-test).
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Figure 2.14. Microbiota α-diversity (Shannon) during in vitro fermentation of protein isolates
under high dietary fiber (HDF) and low dietary fiber (LDF). Error bars show standard deviation
(n=3). Letters are color-coded by protein type and proteins marked with different letters are
significantly different (Tukey’s HSD test p<0.05).
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A

B

Figure 2.15. Differentially abundant features of the microbiome caused by protein isolates after
24 h of in vitro fermentation under (A) high fiber and (B) low fiber conditions [linear
discriminate analysis effect size (LEfSe) >2 and p<0.05 using protein isolate as the class variable
(factorial Kruskal-Wallis test) and microbiome as the subclass variable (Wilcoxon-test)]; colored
nodes indicate microbial taxa with increased abundance on the indicated protein isolates; taxa
with significant differences at the phylum-, class-, order- and family-levels are labeled; genera
with significant differences are not labelled, but are shown in Figure 2.16.
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Figure 2.16. Abundances of genera with significant differences among protein isolates after 24 h
of in vitro fermentation under low fiber conditions [linear discriminate analysis effect size
(LEfSe) >2 and p<0.05 using protein isolate as the class variable and microbiome as the subclass
variable]; protein annotation indicates the protein isolates associated with that genus.
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Figure 2.17. Spearman partial correlations between amino acid concentrations in protein isolates
and mean metabolite production after 24 h of in vitro fermentation under low fiber conditions;
partial variables were microbiome and diet (n=24); *p<0.05, **p<0.01 , ***p<0.001.
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